title: Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).
authors.forename: J
authors.initials: J
authors.lastname: Treat
authors.forename: L R
authors.initials: LR
authors.lastname: Kaiser
authors.forename: D H
authors.initials: DH
authors.lastname: Sterman
authors.forename: L
authors.initials: L
authors.lastname: Litzky
authors.forename: A
authors.initials: A
authors.lastname: Davis
authors.forename: J M
authors.initials: JM
authors.lastname: Wilson
authors.forename: S M
authors.initials: SM
authors.lastname: Albelda
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics*; D000998:Antiviral Agents / Q000494:pharmacology*; D002985:Clinical Protocols; D015774:Ganciclovir / Q000494:pharmacology*; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000201:enzymology*; D006801:Humans; D008654:Mesothelioma / Q000628:therapy*; D011995:Recombination, Genetic; D013937:Thymidine Kinase / Q000235:genetics / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D013937:Thymidine Kinase; D015774:Ganciclovir